DJIA 17,122.01 15.31 0.09%
NASDAQ 4,569.62 -1.02 -0.02%
S&P 500 2,000.12 0.10 0.00%
market minute promo

Repligen Corp (NASDAQ: RGEN)

20.20 -0.46 (-2.23%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

RGEN $20.20 -2.23%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $20.63
Previous Close $20.66
Daily Range $20.09 - $20.73
52-Week Range $9.41 - $24.68
Market Cap $659.5M
P/E Ratio 40.51
Dividend (Yield) $0.00 (0.0%)
Volume 204,321
Average Daily Volume 353,924
Current FY EPS $0.29





Repligen Corp (RGEN) Description

A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system. Website:

News & Commentary

3 Stocks to Get on Your Watchlist

A biopharmaceutical company with an upcoming FDA decision, a discount store attracting possible buyout interest, and a potentially overvalued life sciences company are this week's three must-watch stocks.

Repligen's (RGEN) CEO Walter Herlihy on Q2 2014 Results - Earnings Call Transcript

Sector Update: Health Care

Sector Update: Health-Care Shares Higher Pre-Market

Repligen (RGEN) Q2 2014 Results - Earnings Call Webcast

Repligen (RGEN) Shares March Higher, Can It Continue? - Tale of the Tape

Repligen (RGEN) Shares March Higher, Can It Continue? - Tale of the Tape

Stocks Hitting 52-Week Highs

XBI, MNKD, MACK, RGEN: ETF Outflow Alert

Why Repligen Corporation Shares Vaulted Higher

Repligen shares soar after going shopping, but here's what shareholders may really want to keep their eyes on.

SPDR S&P Biotech ETF Experiences Big Outflow

See More RGEN News...

RGEN's Top Competitors

RGEN $20.20 (-2.23%)
Current stock: RGEN
AMGN $137.83 (0.41%)
Current stock: AMGN
GILD $107.41 (1.07%)
Current stock: GILD
BIIB $343.36 (0.11%)
Current stock: BIIB